Page last updated: 2024-09-03

rc 3095 and bim 23127

rc 3095 has been researched along with bim 23127 in 1 studies

Compound Research Comparison

Studies (rc 3095)	Trials (rc 3095)	Recent Studies (post-2010) (rc 3095)	Studies (bim 23127)	Trials (bim 23127)	Recent Studies (post-2010) (bim 23127)
108	2	26	15	0	4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brunetto, AL; Brunetto, AT; de Farias, CB; Fratini, L; Ghisleni, EC; Gregianin, LJ; Jaeger, M; Roesler, R; Schwartsmann, G	1

Other Studies

1 other study(ies) available for rc 3095 and bim 23127

Article	Year
Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2016, Volume: 32, Issue:1 Topics: Analysis of Variance; Antineoplastic Agents; Apoptosis; Bombesin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; Peptide Fragments; Peptides, Cyclic; Receptors, Bombesin	2016

Article

Year

Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2016, Volume: 32, Issue:1

Topics: Analysis of Variance; Antineoplastic Agents; Apoptosis; Bombesin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Humans; Medulloblastoma; Peptide Fragments; Peptides, Cyclic; Receptors, Bombesin

2016